Related Experiment Videos
[The use of immunotropic therapy in patients with systemic vasculitides]
148 patients with systemic vasculitis (SV) were observed. In 90 of them "in vitro" we evaluated the action of immunotropic mediators (levamisol, timalin, human plasma immunoglobulin, placental polybiolin)--to evaluate the expression of lymphocyte antigens and oxide-renewal phagocyte activity. It was estimated, that the major sensitivity patients--do have lymphocytes to placental polybiolin. We studied the influence of this preparation in SV patients, and its effectivity was compared with glucocorticoids. It was estimated, that placental polybiolin has selective action upon T-lymphocytes subpopulations, improves antigens expression on operating variations of T-lymphocytes, stabilises humorally-regulatory protein figures. Its application effectivity makes 76.7% comparing to glucocorticoids (52.6%) in patients with light and middle degrees of systemic vasculitides hardness--individually sensitive to placental polybiolin.
148 patients with systemic vasculitis (SV) were observed. In 90 of them "in vitro" we evaluated the action of immunotropic mediators (levamisol, timalin, human plasma immunoglobulin, placental polybiolin)--to evaluate the expression of lymphocyte antigens and oxide-renewal phagocyte activity. It was estimated, that the major sensitivity patients--do have lymphocytes to placental polybiolin. We studied the influence of this preparation in SV patients, and its effectivity was compared with glucocorticoids. It was estimated, that placental polybiolin has selective action upon T-lymphocytes subpopulations, improves antigens expression on operating variations of T-lymphocytes, stabilises humorally-regulatory protein figures. Its application effectivity makes 76.7% comparing to glucocorticoids (52.6%) in patients with light and middle degrees of systemic vasculitides hardness--individually sensitive to placental polybiolin.